Carcinogenicity, mutagenicity and teratogenicity of manganese compounds.
Manganese, an essential trace element, is one of the most used metals in the industry. Recently, several new manganese compounds have been introduced as fungicide, as antiknock agent in petrol and as contrasting agent in nuclear magnetic resonance tomography. Manganese displays a somewhat unique behaviour with regard to its toxicity. It is relatively non-toxic to the adult organism except to the brain where it causes Parkinson-like symptoms when inhaled even at moderate amounts over longer periods of time. Relatively high doses of manganese affect DNA replication and repair in bacteria and causes mutations in microorganism and mammalian cells although the Ames test does not appear to be particularly responsive to manganese. In mammalian cells, manganese causes DNA damage and chromosome aberrations. Information on organic manganese derivatives is still insufficient. Large amounts of manganese affect fertility in mammals and are toxic to the embryo and foetus. The fungicide MANEB and the contrasting agent MnDPDP also can be embryotoxic, but the latter only at doses much higher than those clinically employed. Information on the anti-knock agent MMT is inadequate. On the other hand, manganese deficiency can also affect fertility and be teratogenic. Information on cancer due to manganese is scanty but the results available do not indicate that inorganic manganese is carcinogenic. More information is desirable with regard to the organic manganese derivatives. It may surprise that an agent that causes mutations is not also carcinogenic. The experience with manganese shows that conclusions with regard to carcinogenicity of an agent based on the observation of mutations are subject to uncertainties. Altogether, it appears that, because of the very high doses at which positive effects have been found, manganese would not represent a significant carcinogenic risk to the population and workers. Care must, however, be exercised with respect to central-nervous symptoms after chronic exposure and with respect to effects on the embryo. Pregnant women should not be exposed to manganese at the work place.
Gerber
G B
GB
Teratogenicity and Mutagenicity Unit, Catholic University of Louvain, Avenue E. Mounier 72, UCL 7237, B-1200 Brussels, Belgium.
Léonard
A
A
Hantson
Ph
P
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000328:Adult; D000818:Animals; D001419:Bacteria / Q000187:drug effects; D015197:Carcinogenicity Tests; D006224:Cricetinae; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007246:Infertility / Q000139:chemically induced; D008297:Male; D008322:Mammals; D008345:Manganese / Q000172:deficiency; D017895:Manganese Compounds / Q000009:adverse effects*; D020149:Manganese Poisoning / Q000209:etiology / Q000523:psychology; D051379:Mice; D008875:Middle Aged; D009152:Mutagenicity Tests; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009784:Occupational Diseases / Q000139:chemically induced; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D011247:Pregnancy; D051381:Rats
D017895:Manganese Compounds; D008345:Manganese